Issue
Alert me when new journal issues are available via
=free full text
Editorial Board page i Full-Text PDF (34 KB)
Become Part of Our Vision! page ii Full-Text PDF (569 KB)
Monothematic Conference: Liver Transplantation for Viral Hepatitis page iii Full-Text PDF (5075 KB)
41st Annual Meeting of EASL page iv Full-Text PDF (582 KB)
Editorials
Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: Is adefovir dipivoxil the answer?, 08 November 2005 Chloe L. Thio pages 1-3 Full Text | Full-Text PDF (72 KB)
Treating patients with HCV genotype 1 and low viraemia: More than meets the eye, 08 November 2005 Antonio Craxì, Calogero Cammà pages 4-7 Full Text | Full-Text PDF (76 KB)
Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients, 08 November 2005 Maria Varela, Jordi Bruix pages 8-10 Full Text | Full-Text PDF (64 KB)
Forum on Liver Transplantation
Fifth Forum on Liver Transplantation, 08 November 2005 Pierre-Alain Clavien pages 11-12 Full Text | Full-Text PDF (50 KB)
“Will all liver transplantation patients eventually die from cancer?”, 08 November 2005 William Sanchez, Jayant A. Talwalkar, Gregory J. Gores pages 13-18 Full Text | Full-Text PDF (106 KB)
Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?, 08 November 2005 Federico Aucejo, George Rofaiel, Charles Miller pages 19-23 Full Text | Full-Text PDF (90 KB)
What is the current treatment of PTLD after liver transplantation?, 08 November 2005 Jean-François Dufour, Martin F. Fey pages 23-26 Full Text | Full-Text PDF (73 KB)
Skin cancers after liver transplantation: What to do?, 08 November 2005 Sylvie Euvrard, Jean Kanitakis pages 27-32 Full Text | Full-Text PDF (136 KB)
Should we screen for colorectal cancer in liver transplantation?, 08 November 2005 Fabiola Delcò, Beat Müllhaupt pages 32-38 Full Text | Full-Text PDF (129 KB)
Viral Hepatitis
Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan, 13 July 2005 Chun-Jen Liu, Shyh-Chyi Lo, Jia-Horng Kao, Ping-Tsung Tseng, Ming-Yang Lai, Yen-Hsuan Ni, Shiou-Hwei Yeh, Pei-Jer Chen, Ding-Shinn Chen pages 39-46 Abstract | Full Text | Full-Text PDF (190 KB)
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy, 28 July 2005 Norbert Bräu, Mirella Salvatore, Carlos F. Ríos-Bedoya, Alberto Fernández-Carbia, Fiorenzo Paronetto, José F. Rodríguez-Orengo, Maribel Rodríguez-Torres, for the Puerto Rico-New York Hepatitis Study Group pages 47-55 Abstract | Full Text | Full-Text PDF (134 KB)
Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis, 22 August 2005 Louis d'Alteroche, Samuel Majzoub, Anne-Isabelle Lecuyer, Marie-Paule Delplace, Yannick Bacq pages 56-61 Abstract | Full Text | Full-Text PDF (109 KB)
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1, 26 September 2005 Yves Benhamou, Vincent Thibault, Pamela Vig, Vincent Calvez, Anne-Genevieve Marcelin, Marie-Hélène Fievet, Graeme Currie, Chuy G. Chang, Lu Biao, Shelly Xiong, Carol Brosgart, Thierry Poynard pages 62-67 Abstract | Full Text | Full-Text PDF (125 KB)
A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 cases, 26 September 2005 Hiroyuki Yamada, Masaaki Ebara, Tadashi Yamaguchi, Shinichirou Okabe, Hiroyuki Fukuda, Masaharu Yoshikawa, Takashi Kishimoto, Hisahiro Matsubara, Hiroyuki Hachiya, Hiroshi Ishikura, Hiromitsu Saisho pages 68-75 Abstract | Full Text | Full-Text PDF (635 KB)
Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy, 26 September 2005 Chien-Hung Chen, Chuan-Mo Lee, Sheng-Nan Lu, Chi-Sin Changchien, Jyh-Chwan Wang, Jing-Houng Wang, Chao-Hung Hung, Tsung-Hui Hu pages 76-82 Abstract | Full Text | Full-Text PDF (124 KB)
Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse, 26 September 2005 Martina Gerotto, Francesca Dal Pero, Gladis Bortoletto, Alessia Ferrari, Roberta Pistis, Giada Sebastiani, Stefano Fagiuoli, Stefano Realdon, Alfredo Alberti pages 83-87 Abstract | Full Text | Full-Text PDF (94 KB)
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients, 25 October 2005 John G. McHutchison, Keyur Patel, Paul Pockros, Lisa Nyberg, Stephen Pianko, Rosie Z. Yu, F. Andrew Dorr, T. Jesse Kwoh pages 88-96 Abstract | Full Text | Full-Text PDF (153 KB)
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia, 08 November 2005 Stefan Zeuzem, Maria Buti, Peter Ferenci, Jan Sperl, Yves Horsmans, Janusz Cianciara, Endre Ibranyi, Ola Weiland, Stephanie Noviello, Clifford Brass, Janice Albrecht pages 97-103 Abstract | Full Text | Full-Text PDF (116 KB)
Cirrhosis and its Complications
Neuropsychological abnormalities in cirrhosis include learning impairment, 11 July 2005 María Ortiz, Juan Córdoba, Carlos Jacas, Montserrat Flavià, Rafael Esteban, Jaume Guardia pages 104-110 Abstract | Full Text | Full-Text PDF (147 KB)
Histological-hemodynamic correlation in cirrhosis—a histological classification of the severity of cirrhosis, 26 September 2005 Satish Nagula, Dhanpat Jain, Roberto J. Groszmann, Guadalupe Garcia-Tsao pages 111-117 Abstract | Full Text | Full-Text PDF (328 KB)
Transplantation
Cadaveric full-size liver transplantation and the graft alternatives in adults: A comparative study from a single centre, 25 August 2005 Mylène Sebagh, Funda Yilmaz, Vincent Karam, Bruno Falissard, Philippe Ichaï, Bruno Roche, Denis Castaing, Catherine Guettier, Didier Samuel, Daniel Azoulay pages 118-125 Abstract | Full Text | Full-Text PDF (134 KB)
Liver Failure, Growth and Cancer
Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma, 11 July 2005 Michael Lie-A-Ling, Conny T. Bakker, Tanja Deurholt, Ruurdtje Hoekstra, John G. Wesseling, Simon C. Afford, Piter J. Bosma pages 126-133 Abstract | Full Text | Full-Text PDF (313 KB)
Characterization of acute liver failure and development of a continuous risk of death staging system in children, 18 July 2005 Edwin Liu, Todd MacKenzie, Emily L. Dobyns, Chirag R. Parikh, Frederick M. Karrer, Michael R. Narkewicz, Ronald J. Sokol pages 134-141 Abstract | Full Text | Full-Text PDF (201 KB)
Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma, 10 November 2005 Akira Wada, Koji Fukui, Yoshiyuki Sawai, Kazuho Imanaka, Shinichi Kiso, Shinji Tamura, Iichiro Shimomura, Norio Hayashi pages 142-150 Abstract | Full Text | Full-Text PDF (378 KB)
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy, 25 October 2005 Wolfgang Sieghart, Doris Losert, Sabine Strommer, Daniel Cejka, Katharina Schmid, Susanne Rasoul-Rockenschaub, Martin Bodingbauer, Richard Crevenna, Brett P. Monia, Markus Peck-Radosavljevic, Volker Wacheck pages 151-157 Abstract | Full Text | Full-Text PDF (242 KB)
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study, 31 October 2005 Hashem B. El-Serag, Abby B. Siegel, Jessica A. Davila, Yasser H. Shaib, Mikele Cayton-Woody, Russell McBride, Katherine A. McGlynn pages 158-166 Abstract | Full Text | Full-Text PDF (125 KB)
Molecular and Cell Biology
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term, 13 July 2005 Markus Neef, Monika Ledermann, Hans Saegesser, Vreni Schneider, Nicolas Widmer, Laurent Arthur Decosterd, Bertrand Rochat, Juerg Reichen pages 167-175 Abstract | Full Text | Full-Text PDF (672 KB)
Limited iron export by hepatocytes contributes to hepatic iron-loading in the Hfe knockout mouse, 26 September 2005 Anita C.G. Chua, Sarah F. Drake, Carly E. Herbison, John K. Olynyk, Peter J. Leedman, Debbie Trinder pages 176-182 Abstract | Full Text | Full-Text PDF (236 KB)
Genetic and Metabolic Liver Disease
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes, 11 July 2005 Daria Vay, Cristina Rigamonti, Matteo Vidali, Elisa Mottaran, Elisa Alchera, Giuseppa Occhino, Massimo Sartori, Emanuele Albano pages 183-189 Abstract | Full Text | Full-Text PDF (325 KB)
Hepatic steatosis and insulin resistance: Does etiology make a difference?, 13 July 2005 Amedeo Lonardo, Silvia Lombardini, Federica Scaglioni, Lucia Carulli, Matteo Ricchi, Dorval Ganazzi, Luigi Elio Adinolfi, Giuseppe Ruggiero, Nicola Carulli, Paola Loria pages 190-196 Abstract | Full Text | Full-Text PDF (267 KB)
Special Article
Non-alcoholic steatohepatitis: From cell biology to clinical practice, 06 October 2005 Helena Cortez-Pinto, Miguel Carneiro de Moura, Christopher Paul Day pages 197-208 Full Text | Full-Text PDF (189 KB)
Reviews
Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis, 04 November 2005 Daniel A. Langer, Vijay H. Shah pages 209-216 Full Text | Full-Text PDF (304 KB)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies, 10 November 2005 Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi Pagliaro pages 217-231 Full Text | Full-Text PDF (286 KB)
Letters to the Editor
Canalicular membrane localization of hepatocyte aquaporin-8 is preserved in estradiol-17β-d-glucuronide-induced cholestasis, 26 September 2005 Aldo D. Mottino, Flavia I. Carreras, Sergio A. Gradilone, Raúl A. Marinelli, Mary Vore pages 232-233 Full Text | Full-Text PDF (148 KB)
Induction of Angiopoietin-2 gene expression by COX-2: A novel role for COX-2 inhibitors during hepatocarcinogenesis, 31 October 2005 Shinji Tanaka, Jack R. Wands, Shigeki Arii pages 233-235 Full Text | Full-Text PDF (199 KB)
Case Reports
Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis, 26 September 2005 Hitoshi Takagi, Satoshi Hagiwara, Hiroaki Hashizume, Daisuke Kanda, Ken Sato, Naondo Sohara, Satoru Kakizaki, Hitomi Takahashi, Masatomo Mori, Hiroaki Kaneko, Susumu Ohwada, Miharu Ushikai, Keiko Kobayashi, Takeyori Saheki pages 236-239 Abstract | Full Text | Full-Text PDF (209 KB)
A patient with novel ABCB11 gene mutations with phenotypic transition between BRIC2 and PFIC2, 31 October 2005 Ching-Wan Lam, Ka-Ming Cheung, Man-Shan Tsui, Matthew Shu-Ching Yan, Ching-Yin Lee, Sui-Fan Tong pages 240-242 Abstract | Full Text | Full-Text PDF (171 KB)
Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin, 31 October 2005 Ewa Ellis, Martin Wagner, Frank Lammert, Antal Nemeth, Judith Gumhold, Christian P. Strassburg, Christian Kylander, Despina Katsika, Michael Trauner, Curt Einarsson, Hanns-Ulrich Marschall pages 243-245 Abstract | Full Text | Full-Text PDF (76 KB)
Journal Club
Digestive endoscopy and HCV transmission, 04 November 2005 Jean-Pierre Bronowicki pages 246-247 Abstract | Full Text | Full-Text PDF (84 KB)
Announcements page 248 Full-Text PDF (24 KB)
Guide for Authors pages I-IV Full-Text PDF (62 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
